sicboevolution| *ST Target Pharmaceutical: The subsidiary plans to implement production capacity improvement and technological transformation projects with 100 million yuan

*ST Eye Drug AnnouncementsicboevolutionHuangshan Tianmu, a wholly-owned subsidiary of the company, plans to invest about 10sicboevolution,000 million yuan will be used to build a new production workshop in the existing factory area, optimize and transform the original production line, increase production capacity, build an intelligent, digital and information-based factory, and become a modern Chinese medicine production enterprise with market competitiveness.

Tags:

Prev: bestcryptogameapp| Just now, witnessing history! The first breakthrough was 30 trillion yuan!
Next: bestcryptogamingtoinvestin| Sichuan Chengyu Expressway (00107) will pay a final dividend of 0.24 yuan per share on July 11